Since the finding that the therapeutic efficacy of antipsychotic drugs was directly correlated to their affinity for dopamine D2 receptors [80,81], it was first postulated that altered dopamine D2-like receptors was responsible for schizophrenia symptoms. Here, DRD2 is linked to schizophrenia.